$63.3 million of Net Revenue Q2 2024
+25.7% net revenue Comparable Growth: +30.9% Obagi Medical and +20.0% Milk Makeup vs Q2 2023
Adjusted EBITDA of $6.3 million, up +64.5% vs Q2 2023
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. TheTechOutlook.com takes no editorial responsibility for the same.
